Repeated exposure to a conserved antigen drives dynamic clonal and epitope succession
Defining the dynamics of T cell memory formation with epitope-level resolution can inform vaccine design. Longitudinal T cell receptor (TCR) sequencing after COVID-19 mRNA vaccination has enabled detailed tracking of T cell responses; however, connecting expanded clonotypes following antigen exposure to their cognate epitopes remains a challenge due to limited curated paired α/βTCR information. To fill this gap, we used TIRTL-seq to identify paired α/βTCRs from CD8+ T cell lineages associated with mRNA immunization in serial samples across 38 healthy donors over multiple rounds of vaccinations. Vaccine-associated paired α/βTCRs, identified based on their longitudinal kinetics, were grouped according to sequence similarity to infer their shared epitope specificities. We assigned epitope specificity to 1,109 clonotypes, recognizing 15 SARS-CoV-2 spike targets, identifying multiple previously undescribed responses, and confirming putative specificities experimentally. This approach uncovered a striking pattern of clonal succession in anti-spike T cell memory lineages resulting from repeated vaccination, characterized by a transition from low-avidity clones recognizing conserved coronavirus epitopes to high-avidity clones targeting epitopes unique to SARS-CoV-2. These results highlight the surprisingly dynamic responses underlying homologous boosting, suggest avenues for improving vaccine strategies, and pave the way for repertoire-based monitoring of antigen-specific T cell immunity.
Authors
- Stefan Schattgen (ORCID: https://orcid.org/0000-0002-6860-5079)
- Hiroyasu Aoki (ORCID: https://orcid.org/0000-0001-7068-715X)
- Kouji Matsushima (ORCID: https://orcid.org/0000-0003-1056-171X)
- Satoshi Ueha (ORCID: https://orcid.org/0000-0002-3871-9921)
- Noriko Ouji-Sageshima (ORCID: https://orcid.org/0009-0003-8876-4717)
- Anastasia A. Minervina (ORCID: https://orcid.org/0000-0001-9884-6351)
- Toshihiro Ito (ORCID: https://orcid.org/0000-0003-1728-2449)
- Chihiro Motozono (ORCID: https://orcid.org/0000-0002-9027-742X)
- Federica Sallusto (ORCID: https://orcid.org/0000-0003-3750-2752)
- Koshlan Mayer-Blackwell (ORCID: https://orcid.org/0000-0002-1652-4023)
- Masahiro Kitabatake
- Antonio Lanzavecchia (ORCID: https://orcid.org/0000-0002-3041-7240)
- Philip H Bradley (ORCID: https://orcid.org/0000-0002-0224-6464)
- Kasi Vegesana (ORCID: https://orcid.org/0000-0001-8847-3774)
- Mikhail V. Pogorelyy (ORCID: https://orcid.org/0000-0003-0773-1204)
- Velmurugan Balaraman (ORCID: https://orcid.org/0000-0003-1671-5572)
- Paul G. Thomas (ORCID: https://orcid.org/0000-0001-7955-0256)
- Atsushi Hara
- Zachary B. Scott
- Peng Xu
- Cecilia Adragna (ORCID: https://orcid.org/0009-0008-2924-6641)
- E. Kaitlynn Allen
Institutions
- St. Jude Children's Research Hospital (US)
- Tokyo University of Science (JP)
- Fred Hutch Cancer Center (US)
- Institute for Research in Biomedicine (ES)
- Nara Medical University (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.64898/2026.11.12.763997
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- preprint
Funders
- Cancer Research Institute
- Fred Hutchinson Cancer Research Center
- University of Washington
- Japan Agency for Medical Research and Development
- National Institutes of Health
- Japan Society for the Promotion of Science